Brief: Catabasis Pharmaceuticals Renames To Astria Therapeutics

Astria Therapeutics

08/09/2021 13:32

Sept 8 (Reuters) - Catabasis Pharmaceuticals Inc  CATB.O :
    * CATABASIS PHARMACEUTICALS ANNOUNCES NEW COMPANY NAME,
ASTRIA
THERAPEUTICS
    * CATABASIS PHARMACEUTICALS INC - EXPECTS TO BEGIN TRADING
UNDER
NEW TICKER SYMBOL "ATXS" ON NASDAQ GLOBAL SELECT MARKET AT
MARKET OPEN ON SEPTEMBER 9
    * CATABASIS PHARMACEUTICALS INC - EXPECTS TO FILE IND
APPLICATION
FOR STAR-0215 IN MID-2022
    * CATABASIS PHARMACEUTICALS - PLANS TO INITIATE PHASE 1
CLINICAL
TRIAL WITH INITIAL PROOF OF CONCEPT RESULTS ANTICIPATED BY YEAR
END 2022 FOR STAR-0125

Source text for Eikon:  ID:nBw3StQHMa 
Further company coverage:  CATB.O 

 ((Reuters.Briefs@thomsonreuters.com;))